BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng SW, Chen PC, Ger TR, Chiu HW, Lin YF. GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy. J Pers Med 2021;11:197. [PMID: 33809079 DOI: 10.3390/jpm11030197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Meehan J. Special Issue “Cancer Biomarker Research and Personalized Medicine”. JPM 2022;12:585. [DOI: 10.3390/jpm12040585] [Reference Citation Analysis]
2 Wardhani BWK, Louisa M, Watanabe Y, Setiabudy R, Kato M. TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration. Breast Cancer (Dove Med Press) 2021;13:529-38. [PMID: 34584450 DOI: 10.2147/BCTT.S325429] [Reference Citation Analysis]